These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
98 related items for PubMed ID: 9169487
1. A synthetic peptide inhibitor for alpha-chemokines inhibits the growth of melanoma cell lines. Hayashi S, Kurdowska A, Cohen AB, Stevens MD, Fujisawa N, Miller EJ. J Clin Invest; 1997 Jun 01; 99(11):2581-7. PubMed ID: 9169487 [Abstract] [Full Text] [Related]
2. Inhibition of GROalpha-induced human endothelial cell proliferation by the alpha-chemokine inhibitor antileukinate. Fujisawa N, Hayashi S, Kurdowska A, Carr FK, Miller EJ. Cytokine; 1999 Mar 01; 11(3):231-8. PubMed ID: 10209071 [Abstract] [Full Text] [Related]
3. Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes. Bordoni R, Fine R, Murray D, Richmond A. J Cell Biochem; 1990 Dec 01; 44(4):207-19. PubMed ID: 2095366 [Abstract] [Full Text] [Related]
5. Melanoma growth stimulatory activity: isolation from human melanoma tumors and characterization of tissue distribution. Richmond A, Thomas HG. J Cell Biochem; 1988 Feb 01; 36(2):185-98. PubMed ID: 3356754 [Abstract] [Full Text] [Related]
10. CXC chemokines suppress proliferation of myeloid progenitor cells by activation of the CXC chemokine receptor 2. Sanchez X, Suetomi K, Cousins-Hodges B, Horton JK, Navarro J. J Immunol; 1998 Jan 15; 160(2):906-10. PubMed ID: 9551928 [Abstract] [Full Text] [Related]
11. Melanoma growth stimulatory activity in primary malignant melanoma: prognostic significance. Middleman BR, Friedman M, Lawson DH, DeRose PB, Cohen C. Mod Pathol; 2002 May 15; 15(5):532-7. PubMed ID: 12011258 [Abstract] [Full Text] [Related]
12. Characterization of autostimulatory and transforming growth factors from human melanoma cells. Richmond A, Lawson DH, Nixon DW, Chawla RK. Cancer Res; 1985 Dec 15; 45(12 Pt 1):6390-4. PubMed ID: 3864531 [Abstract] [Full Text] [Related]
13. Growth factor modulation of melanoma growth stimulatory activity mRNA expression in human malignant melanoma cells correlates with cell growth. Bordoni R, Thomas G, Richmond A. J Cell Biochem; 1989 Apr 15; 39(4):421-8. PubMed ID: 2722970 [Abstract] [Full Text] [Related]
14. Purification of melanoma growth stimulatory activity. Richmond A, Thomas HG. J Cell Physiol; 1986 Dec 15; 129(3):375-84. PubMed ID: 3465735 [Abstract] [Full Text] [Related]
15. A His19 to Ala mutant of melanoma growth-stimulating activity is a partial antagonist of the CXCR2 receptor. Baly DL, Horuk R, Yansura DG, Simmons LC, Fairbrother WJ, Kotts C, Wirth CM, Gillece-Castro BL, Toy K, Hesselgesser J, Allison DE. J Immunol; 1998 Nov 01; 161(9):4944-9. PubMed ID: 9794430 [Abstract] [Full Text] [Related]
19. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid. Ahrens T, Sleeman JP, Schempp CM, Howells N, Hofmann M, Ponta H, Herrlich P, Simon JC. Oncogene; 2001 Jun 07; 20(26):3399-408. PubMed ID: 11423990 [Abstract] [Full Text] [Related]
20. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1. Kortylewski M, Heinrich PC, Mackiewicz A, Schniertshauer U, Klingmüller U, Nakajima K, Hirano T, Horn F, Behrmann I. Oncogene; 1999 Jun 24; 18(25):3742-53. PubMed ID: 10391682 [Abstract] [Full Text] [Related] Page: [Next] [New Search]